AVTR

AVTR

USD

Avantor Inc. Common Stock

$12.870-0.330 (-2.500%)

Reaalajas hind

Healthcare
Medical Instruments & Supplies
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$13.200

Kõrge

$13.360

Madal

$12.725

Maht

1.13M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

8.8B

Tööstusharu

Medical Instruments & Supplies

Riik

United States

Kauplemisstatistika

Keskmine maht

10.13M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $12.195Praegune $12.870Kõrge $28

Seotud uudised

PR Newswire

Avantor® to Participate in Bank of America Securities 2025 Health Care Conference

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced...

Vaata rohkem
Avantor® to Participate in Bank of America Securities 2025 Health Care Conference
Analyst Upgrades

Goldman Sachs Downgrades Avantor to Neutral, Lowers Price Target to $14

Goldman Sachs analyst Matthew Sykes downgrades Avantor from Buy to Neutral and lowers the price target from $23 to $14.

Vaata rohkem
Goldman Sachs Downgrades Avantor to Neutral, Lowers Price Target to $14
Analyst Upgrades

RBC Capital Maintains Outperform on Avantor, Lowers Price Target to $20

RBC Capital analyst Conor McNamara maintains Avantor with a Outperform and lowers the price target from $24 to $20.

Vaata rohkem
RBC Capital Maintains Outperform on Avantor, Lowers Price Target to $20
Analyst Upgrades

Stifel Downgrades Avantor to Hold, Lowers Price Target to $14

Stifel analyst Daniel Arias downgrades Avantor from Buy to Hold and lowers the price target from $26 to $14.

Vaata rohkem
Stifel Downgrades Avantor to Hold, Lowers Price Target to $14
Analyst Upgrades

Morgan Stanley Downgrades Avantor to Equal-Weight, Lowers Price Target to $15

Morgan Stanley analyst Tejas Savant downgrades Avantor from Overweight to Equal-Weight and lowers the price target from $25 to $15.

Vaata rohkem
Morgan Stanley Downgrades Avantor to Equal-Weight, Lowers Price Target to $15
Analyst Upgrades

Baird Maintains Outperform on Avantor, Lowers Price Target to $17

Baird analyst Catherine Schulte maintains Avantor with a Outperform and lowers the price target from $21 to $17.

Analyst Upgrades

Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift

Avantor matched EPS expectations but missed revenue targets and cut its outlook as its CEO steps down and cost-saving plans ramp up.

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.